seekingalpha.com
SIGA Technologies, Inc. (SIGA) Q4 2025 Earnings Call Transcript
SIGA Technologies, Inc. (SIGA) Q4 2025 Earnings Call Transcript
SIGA Technologies, Inc.SIGANASDAQ
Loading
Latest News
Loading news...
globenewswire.com
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months ended December 31, 2025.
globenewswire.com
SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, March 10, 2026.
defenseworld.net
Stock Traders Buy Large Volume of Call Options on Siga Technologies (NASDAQ:SIGA)
Siga Technologies Inc. (NASDAQ: SIGA - Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock investors acquired 1,200 call options on the company. This represents an increase of 1,438% compared to the average daily volume of 78 call options. Siga Technologies Price Performance NASDAQ: SIGA opened at $6.73 on Thursday. The
defenseworld.net
Traders Purchase Large Volume of Call Options on Siga Technologies (NASDAQ:SIGA)
Siga Technologies Inc. (NASDAQ: SIGA - Get Free Report) was the target of unusually large options trading on Wednesday. Traders bought 1,200 call options on the company. This is an increase of approximately 1,438% compared to the typical volume of 78 call options. Wall Street Analyst Weigh In A number of analysts recently commented on the
defenseworld.net
Takeda Pharmaceutical (NYSE:TAK) vs. Siga Technologies (NASDAQ:SIGA) Head-To-Head Review
Siga Technologies (NASDAQ: SIGA - Get Free Report) and Takeda Pharmaceutical (NYSE: TAK - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, profitability, valuation and risk. Analyst Recommendations This is a summary of current
defenseworld.net
Siga Technologies Sees Unusually Large Options Volume (NASDAQ:SIGA)
Siga Technologies Inc. (NASDAQ: SIGA - Get Free Report) saw some unusual options trading on Wednesday. Traders purchased 1,200 call options on the stock. This represents an increase of approximately 1,438% compared to the typical daily volume of 78 call options. Institutional Inflows and Outflows Institutional investors and hedge funds have recently added to or reduced
defenseworld.net
Siga Technologies Inc. $SIGA Shares Sold by Aviva PLC
Aviva PLC trimmed its holdings in Siga Technologies Inc. (NASDAQ: SIGA) by 51.7% in the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 51,144 shares of the company's stock after selling 54,717 shares during the period. Aviva PLC owned approximately 0.07% of Siga Technologies worth $333,000 at
seekingalpha.com
SIGA Technologies, Inc. (SIGA) Q3 2025 Earnings Call Transcript
SIGA Technologies, Inc. ( SIGA ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Diem Nguyen - CEO & Director Daniel Luckshire - Executive VP, CFO & Secretary Conference Call Participants Jyoti Prakash - Edison Investment Research Limited Presentation Operator Welcome to the SIGA Business Update Call. Before we turn the call over to SIGA management, please note that any forward-looking statements made during this call are based on management's current expectations and observations and are subject to risks and uncertainties that could cause actual results to differ from the forward-looking statements.
globenewswire.com
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30, 2025. “We continue to advance SIGA's key priorities while generating $86 million in product revenues and $33 million in pre-tax operating income for the first nine months of 2025," stated Diem Nguyen, Chief Executive Officer.
globenewswire.com
SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, November 6, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.
businesswire.com
Saskatchewan Indian Gaming Authority (SIGA) Modernizes Point-of-Sale and Inventory Operations Across Seven Casinos with Agilysys Solutions
ALPHARETTA, Ga.--(BUSINESS WIRE)--Agilysys, Inc. (Nasdaq: AGYS), a leading global provider of hospitality software and services, today announced that the Saskatchewan Indian Gaming Authority (SIGA) has chosen Agilysys InfoGenesis POS and Agilysys Eatec inventory and procurement solutions for enterprise-wide use across all seven of its casino properties in Saskatchewan. This milestone represents a major advancement in SIGA's strategy to modernize its operations at scale. This modernization initi.
forbes.com
7 Big Yields From The Beat-Up Healthcare Sector
Healthcare stocks haven't moved since the April lows. As contrarian investors, this neglect piques our interest.
seekingalpha.com
SIGA Technologies: Still Bullish, But Worth Trimming Ahead Of BARDA News
SIGA's investment thesis is overwhelmingly tied to the renewal of the BARDA contract, which remains highly uncertain due to political and budgetary risks. Recent revenue growth and a strong balance sheet are positives, but the company faces label risk in the EU and heavy reliance on U.S. government funding. Potential catalysts include TPOXX label expansion for post-exposure prophylaxis and a new BARDA contract, while EU label changes and U.S. defunding are key risks.
seekingalpha.com
SIGA Technologies, Inc. (SIGA) Q2 2025 Earnings Call Transcript
SIGA Technologies, Inc. (NASDAQ:SIGA ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Daniel J. Luckshire - Executive VP, CFO & Secretary Diem Nguyen - CEO & Director Conference Call Participants Jyoti Prakash - Edison Investment Research Limited Operator Welcome to the SIGA Business Update Call.
globenewswire.com
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and six months ended June 30, 2025.
fool.com
3 Healthcare Stocks Paying the Highest Dividends of 2025
The healthcare sector has long been a favorite for income investors -- and for good reason. Many healthcare stocks offer attractive dividend yields.
globenewswire.com
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.
zacks.com
Siga Technologies Inc. (SIGA) Stock Falls Amid Market Uptick: What Investors Need to Know
Siga Technologies Inc. (SIGA) closed at $7.06 in the latest trading session, marking a -1.4% move from the prior day.